未登录

L

Luís Tortosa

health research institute la fe

H指数:9

被引数:318

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn’s Disease: An Observational Study

白细胞介素动力学在乌司奴单抗诱导期间作为克罗恩病治疗反应的预测指标：一项观察性研究

IF3.9

2026-03-030

OAAI

Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY

IF3

2021-10-017

OAAI

Ustekinumab levels correlate with induction fecal calprotectin drop-slope and discriminate the need for intensification at week 52 in Crohn's Disease patients

JOURNAL OF CROHNS & COLITIS

IF8.7

2021-05-271

PRE

Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's Disease

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY

IF3

2019-10-2824

OAAI

SPECIFIC CYTOKINE PROFILES TO IDENTIFY RESPONSE TO ANTI TUMOR NECROSIS FACTOR α BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE

GASTROENTEROLOGY

IF25.1

2019-02-010

PREAI

Differential cytokine profiles and drop of faecal calprotectin for prediction of primary response to infliximab induction therapy in Crohn's disease

JOURNAL OF CROHNS & COLITIS

IF8.7

2019-01-250

OAAI

Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

JOURNAL OF CROHNS & COLITIS

IF8.7

2019-01-250

OAAI

Alpha-defensins (α-Defs) in Crohn's disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utility

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2018-01-107

OAAI

α-Defensins(αDef) 1-3 Are Specific Plasmatic Markers for Crohn's Disease (CD) at Diagnosis and Tissue α-Def 5 Methylation Is a Pathogenic Mechanism for αDef-5 Down Regulation in CD

GASTROENTEROLOGY

IF25.1

2016-04-010

OAAI